Cytosorbents (CTSO) EBITDA Margin Growth (1y) (2012 - 2026)
Cytosorbents (CTSO) EBITDA Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 146.00 |
| 10 | Cytosorbents | 21.98 Mn | 17.56 Mn | 7.05 Mn | 1,020.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,020.00 |
| Mar 31, 2026 | 1,021.00 |
| Dec 31, 2025 | -1,039.00 |
| Sep 30, 2025 | 2,590.00 |
| Jun 30, 2025 | 279.00 |
| Mar 31, 2025 | 725.00 |
| Dec 31, 2024 | 7,144.00 |
| Sep 30, 2024 | 2,734.00 |
| Jun 30, 2024 | 2,925.00 |
| Mar 31, 2024 | 3,172.00 |
| Dec 31, 2023 | -4,085.00 |
| Sep 30, 2023 | 2,775.00 |
| Jun 30, 2023 | 2,874.00 |
| Mar 31, 2023 | 613.00 |
| Dec 31, 2022 | 2,099.00 |
| Sep 30, 2022 | -5,578.00 |
| Jun 30, 2022 | -5,741.00 |
| Mar 31, 2022 | -6,273.00 |
| Dec 31, 2021 | -6,665.00 |
| Sep 30, 2021 | -3,681.00 |